Skip to main content
Top
Published in: BMC Anesthesiology 1/2018

Open Access 01-12-2018 | Research article

Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy

Authors: Catherine Chiu, Pedram Aleshi, Laura J. Esserman, Christina Inglis-Arkell, Edward Yap, Elizabeth L. Whitlock, Monica W. Harbell

Published in: BMC Anesthesiology | Issue 1/2018

Login to get access

Abstract

Background

Enhanced Recovery After Surgery (ERAS) pathways have been shown in multiple surgical disciplines to improve outcomes, including reduced opioid consumption, length of stay, and post-operative nausea and vomiting (PONV). However, very few studies describe the application of ERAS to breast surgery and even fewer describe ERAS for outpatient surgery. We describe the implementation and efficacy of an Enhanced Recovery After Surgery (ERAS) pathway for total skin-sparing mastectomy with immediate reconstruction in an outpatient setting.

Methods

We implemented an evidence-based, multimodal ERAS pathway for all patients undergoing total skin-sparing mastectomy surgery with immediate reconstruction at a single 23-h stay surgery center. Highlights of the ERAS pathway included: preoperative acetaminophen, gabapentin, and scopolamine; regional anesthesia for the breast (Pectoral blocks type 1 and 2 or paravertebral block); and intraoperative dexamethasone and ondansetron. This retrospective study included all American Society of Anesthesiology (ASA) Class 1–3 patients undergoing total skin-sparing mastectomy surgery with immediate reconstruction between July 2013 and April 2016. We compared 96 patients who were in the ERAS pathway (ERAS group) to a retrospective cohort of 276 patients (Pre group). The primary outcome was total perioperative opioid consumption. Secondary outcomes were highest postoperative pain scores, incidence of PONV, and length of stay.

Results

Patients in the ERAS group had significantly lower total perioperative opioid consumption compared to the Pre group (mean (SD): 111.4 mg (46.0) vs. 163.8 mg (73.2) oral morphine equivalents, p < 0.001). Patients in the ERAS group also had a lower incidence of PONV (28% vs. 50%, p < 0.001). Patients in the ERAS group reported less pain in the recovery room, with a two-point decrease in highest pain score (median [interquartile range (IQR)]: 4 [2,6] in ERAS group vs. 6 [4,7] in Pre group, p < 0.001). There was no clinically significant difference in length of stay (median [IQR]: 1144 min [992, 1259] in ERAS group vs. 1188 [1058, 1344] in Pre group, p = 0.006).

Conclusion

Implementation of an ERAS pathway for total skin-sparing mastectomy with reconstruction that incorporates regional anesthesia is feasible in a 23-h-stay hospital. Patients in the ERAS pathway had improved post-operative analgesia and reduced post-operative nausea and vomiting.
Appendix
Available only for authorised users
Literature
1.
go back to reference U. S. C. S. W. Group. United States Cancer statistics: 1999-2012 incidence and mortality web-based report. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2015. U. S. C. S. W. Group. United States Cancer statistics: 1999-2012 incidence and mortality web-based report. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2015.
2.
go back to reference Alves Nogueira Fabro E, et al. “Post-mastectomy pain syndrome: incidence and risks,” (in eng). Breast. 2012;21(3):321–5.CrossRefPubMed Alves Nogueira Fabro E, et al. “Post-mastectomy pain syndrome: incidence and risks,” (in eng). Breast. 2012;21(3):321–5.CrossRefPubMed
3.
go back to reference Gärtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. “Prevalence of and factors associated with persistent pain following breast cancer surgery”, (in eng). JAMA. 2009;302(18):1985–92.CrossRefPubMed Gärtner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H. “Prevalence of and factors associated with persistent pain following breast cancer surgery”, (in eng). JAMA. 2009;302(18):1985–92.CrossRefPubMed
4.
go back to reference Kehlet H, Jensen TS, Woolf CJ. “Persistent postsurgical pain: risk factors and prevention,” (in eng). Lancet. 2006;367(9522):1618–25.CrossRefPubMed Kehlet H, Jensen TS, Woolf CJ. “Persistent postsurgical pain: risk factors and prevention,” (in eng). Lancet. 2006;367(9522):1618–25.CrossRefPubMed
5.
go back to reference Sinatra R. “Causes and consequences of inadequate management of acute pain,” (in eng). Pain Med. 2010;11(12):1859–71.CrossRefPubMed Sinatra R. “Causes and consequences of inadequate management of acute pain,” (in eng). Pain Med. 2010;11(12):1859–71.CrossRefPubMed
7.
go back to reference Dowell D, Haegerich TM, Chou R. “CDC guideline for prescribing opioids for chronic pain--United States, 2016,” (in eng). JAMA. 2016;315(15):1624–45.CrossRefPubMed Dowell D, Haegerich TM, Chou R. “CDC guideline for prescribing opioids for chronic pain--United States, 2016,” (in eng). JAMA. 2016;315(15):1624–45.CrossRefPubMed
8.
go back to reference Wu CL, et al. “Initiating an enhanced recovery pathway program: an anesthesiology Department's perspective,” (in eng). Jt Comm J Qual Patient Saf. 2015;41(10):447–56.CrossRefPubMed Wu CL, et al. “Initiating an enhanced recovery pathway program: an anesthesiology Department's perspective,” (in eng). Jt Comm J Qual Patient Saf. 2015;41(10):447–56.CrossRefPubMed
9.
go back to reference Joliat GR, et al. Cost-benefit analysis of the implementation of an Enhanced Recovery Program in Liver Surgery. World J Surg. 2016;40(10):2441–50. Joliat GR, et al. Cost-benefit analysis of the implementation of an Enhanced Recovery Program in Liver Surgery. World J Surg. 2016;40(10):2441–50.
10.
go back to reference Forsmo HM, et al. “Compliance with enhanced recovery after surgery criteria and preoperative and postoperative counselling reduces length of hospital stay in colorectal surgery: results of a randomized controlled trial,” (in eng). Color Dis. 2016;18(6):603–11.CrossRef Forsmo HM, et al. “Compliance with enhanced recovery after surgery criteria and preoperative and postoperative counselling reduces length of hospital stay in colorectal surgery: results of a randomized controlled trial,” (in eng). Color Dis. 2016;18(6):603–11.CrossRef
11.
go back to reference Batdorf NJ, et al. “Enhanced recovery after surgery in microvascular breast reconstruction,” (in eng). J Plast Reconstr Aesthet Surg. 2015;68(3):395–402.CrossRefPubMed Batdorf NJ, et al. “Enhanced recovery after surgery in microvascular breast reconstruction,” (in eng). J Plast Reconstr Aesthet Surg. 2015;68(3):395–402.CrossRefPubMed
12.
go back to reference Dumestre DO, Webb CE, Temple-Oberle C. “Improved recovery experience achieved for women undergoing implant-based breast reconstruction using an enhanced recovery after surgery model,” (in eng). Plast Reconstr Surg. 2017;139(3):550–9.CrossRefPubMed Dumestre DO, Webb CE, Temple-Oberle C. “Improved recovery experience achieved for women undergoing implant-based breast reconstruction using an enhanced recovery after surgery model,” (in eng). Plast Reconstr Surg. 2017;139(3):550–9.CrossRefPubMed
13.
go back to reference Gignoux B, Pasquer A, Vulliez A, Lanz T. “Outpatient colectomy within an enhanced recovery program,” (in eng). J Visc Surg. 2015;152(1):11–5.CrossRefPubMed Gignoux B, Pasquer A, Vulliez A, Lanz T. “Outpatient colectomy within an enhanced recovery program,” (in eng). J Visc Surg. 2015;152(1):11–5.CrossRefPubMed
14.
go back to reference Hoorntje A, Koenraadt KLM, Boevé MG, van Geenen RCI. “Outpatient unicompartmental knee arthroplasty: who is afraid of outpatient surgery?” (in eng). Knee Surg Sports Traumatol Arthrosc. 2017;25(3):759–66.CrossRefPubMedPubMedCentral Hoorntje A, Koenraadt KLM, Boevé MG, van Geenen RCI. “Outpatient unicompartmental knee arthroplasty: who is afraid of outpatient surgery?” (in eng). Knee Surg Sports Traumatol Arthrosc. 2017;25(3):759–66.CrossRefPubMedPubMedCentral
15.
go back to reference Blanco R. “The ‘pecs block’: a novel technique for providing analgesia after breast surgery,” (in eng). Anaesthesia. 2011;66(9):847–8.CrossRefPubMed Blanco R. “The ‘pecs block’: a novel technique for providing analgesia after breast surgery,” (in eng). Anaesthesia. 2011;66(9):847–8.CrossRefPubMed
16.
go back to reference Blanco R, Fajardo M, Parras Maldonado T. “Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery,” (in eng). Rev Esp Anestesiol Reanim. 2012;59(9):470–5.CrossRefPubMed Blanco R, Fajardo M, Parras Maldonado T. “Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery,” (in eng). Rev Esp Anestesiol Reanim. 2012;59(9):470–5.CrossRefPubMed
17.
go back to reference Temple-Oberle C, et al. “Consensus review of optimal perioperative care in breast reconstruction: enhanced recovery after surgery (ERAS) society recommendations,” (in eng). Plast Reconstr Surg. 2017;139(5):1056e–71e.CrossRefPubMed Temple-Oberle C, et al. “Consensus review of optimal perioperative care in breast reconstruction: enhanced recovery after surgery (ERAS) society recommendations,” (in eng). Plast Reconstr Surg. 2017;139(5):1056e–71e.CrossRefPubMed
18.
go back to reference Naja Z, Lönnqvist PA. “Somatic paravertebral nerve blockade. Incidence of failed block and complications,” (in eng). Anaesthesia. 2001;56(12):1184–8.CrossRefPubMed Naja Z, Lönnqvist PA. “Somatic paravertebral nerve blockade. Incidence of failed block and complications,” (in eng). Anaesthesia. 2001;56(12):1184–8.CrossRefPubMed
19.
go back to reference Fernández-Guisasola J, Gómez-Arnau JI, Cabrera Y, del Valle SG. “Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: a systematic review and meta-analysis,” (in eng). Anaesthesia. 2010;65(4):379–87.CrossRefPubMed Fernández-Guisasola J, Gómez-Arnau JI, Cabrera Y, del Valle SG. “Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: a systematic review and meta-analysis,” (in eng). Anaesthesia. 2010;65(4):379–87.CrossRefPubMed
20.
go back to reference Hammas B, Thörn SE, Wattwil M. “Superior prolonged antiemetic prophylaxis with a four-drug multimodal regimen - comparison with propofol or placebo,” (in eng). Acta Anaesthesiol Scand. 2002;46(3):232–7.CrossRefPubMed Hammas B, Thörn SE, Wattwil M. “Superior prolonged antiemetic prophylaxis with a four-drug multimodal regimen - comparison with propofol or placebo,” (in eng). Acta Anaesthesiol Scand. 2002;46(3):232–7.CrossRefPubMed
21.
go back to reference Sadhasivam S, Saxena A, Kathirvel S, Kannan TR, Trikha A, Mohan V. “The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy,” (in eng). Anesth Analg. 1999;89(6):1340–5.PubMed Sadhasivam S, Saxena A, Kathirvel S, Kannan TR, Trikha A, Mohan V. “The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy,” (in eng). Anesth Analg. 1999;89(6):1340–5.PubMed
22.
go back to reference Sarin A, Litonius ES, Naidu R, Yost CS, Varma MG, Chen LL. “Successful implementation of an enhanced recovery after surgery program shortens length of stay and improves postoperative pain, and bowel and bladder function after colorectal surgery,” (in eng). BMC Anesthesiol. 2016;16(1):55.CrossRefPubMedPubMedCentral Sarin A, Litonius ES, Naidu R, Yost CS, Varma MG, Chen LL. “Successful implementation of an enhanced recovery after surgery program shortens length of stay and improves postoperative pain, and bowel and bladder function after colorectal surgery,” (in eng). BMC Anesthesiol. 2016;16(1):55.CrossRefPubMedPubMedCentral
23.
go back to reference Montgomery GH, Schnur JB, Erblich J, Diefenbach MA, Bovbjerg DH. “Presurgery psychological factors predict pain, nausea, and fatigue one week after breast cancer surgery,” (in eng). J Pain Symptom Manag. 2010;39(6):1043–52.CrossRef Montgomery GH, Schnur JB, Erblich J, Diefenbach MA, Bovbjerg DH. “Presurgery psychological factors predict pain, nausea, and fatigue one week after breast cancer surgery,” (in eng). J Pain Symptom Manag. 2010;39(6):1043–52.CrossRef
Metadata
Title
Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy
Authors
Catherine Chiu
Pedram Aleshi
Laura J. Esserman
Christina Inglis-Arkell
Edward Yap
Elizabeth L. Whitlock
Monica W. Harbell
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2018
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-018-0505-9

Other articles of this Issue 1/2018

BMC Anesthesiology 1/2018 Go to the issue